Bavar­i­an Nordic to test its Covid-19 boost­er against Pfiz­er/BioN­Tech shot in piv­otal study

As Bavar­i­an Nordic has made strides re­cent­ly to beef up its small­pox vac­cine man­u­fac­tur­ing in the wake of new mon­key­pox cas­es, the com­pa­ny is al­so get­ting ready to eval­u­ate its Covid-19 boost­er in a piv­otal study. And it’s go­ing af­ter one of the heavy­weights.

The Copen­hagen-based com­pa­ny an­nounced Thurs­day morn­ing it will be pit­ting its Covid-19 boost­er shot against Pfiz­er and BioN­Tech’s boost­er, re­design­ing its Phase III study to in­clude the com­para­tor. Bavar­i­an Nordic said the change will not im­pact its da­ta read­out time­line, ex­pect­ed be­fore the end of the year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.